Dalbavancin Use in Bone and Joint Infections
Our findings support DAL as an effective treatment for bone and joint infection when combined with surgical debridement and hardware removal. Failure to remove infected hardware significantly increased the risk of infection recurrence within 1 year. Randomized controlled trials are needed to further support DAL as a novel treatment for orthopedic infections.
Authors
- Benjamin M. Stronach (ORCID: https://orcid.org/0000-0003-2554-5157)
- Brett Bailey
- C. Lowry Barnes
- Srivani Sanikommu (ORCID: https://orcid.org/0000-0002-1037-8280)
- Simon C. Mears (ORCID: https://orcid.org/0000-0002-0068-0283)
- Jeffrey B. Stambough (ORCID: https://orcid.org/0000-0003-0950-5227)
- Ryan K Dare (ORCID: https://orcid.org/0000-0001-9540-2683)
- Jennifer McDonald
- Traci Motes
- Liam P Alderson
Institutions
- University of Arkansas for Medical Sciences (US)
Publication Details
- Journal
- Arthroplasty Today
- Published
- 2024-10-11
- DOI
- https://doi.org/10.1016/j.artd.2024.101505
- Citations
- 2
- Primary Topic
- Orthopedic Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.15